Keld Fosgerau

1 ta ish

Zealand Pharma (Denmark)

1. Peptide therapeutics: current status and future directions

   Keld Fosgerau, Torsten Hoffmann

   Sharh maqola20144 iqtibos

   ABIABI:AkademIndex/2026.other.434119